Skip to main content
SpringerLink
Log in
Book cover

Operative Neuromodulation pp 145–154Cite as

Intrathecal baclofen in current neuromodulatory practice: established indications and emerging applications

  • Chapter

Part of the book series: Acta Neurochirurgica Supplements ((NEUROCHIRURGICA,volume 97/1))

Summary

Intrathecal baclofen (ITB) has evolved into a standard treatment for severe spasticity of both spinal and cerebral origin. The accumulated promising data from reported series of patients receiving ITB therapy together with the fact that spastic hypertonia commonly coexists with other neurological disorders have constituted a solid basis for offering this kind of treatment to patients suffering from other movement disorders. These include motor disorders such as dystonia, amyotrophic lateral sclerosis, status dystonicus, Hallervorden-Spatz disease, Freidreich’s ataxia, “stiff-man” syndrome, but also vegetative states after severe brain trauma, anoxic encephalopathy or other pathology and more recently, various chronic pain syndromes. In this article, on the basis of the established applications of ITB therapy, we review the important emerging indications of this rewarding neuromodulation method and attempt to identify its future potential beneficial role in other chronic and otherwise refractory neurological disorders.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albright AL, Cervi A, Singletary J (1991) Intrathecal baclofen for spasticity in cerebral palsy. JAMA 265: 1418–1422

    Article  PubMed  CAS  Google Scholar 

  2. Albright LA, Barron WB, Fasick MP, Polinko P, Janosky J (1993) Continuous intrathecal baclofen infusion for infusion for spasticity of cerebral origin. JAMA 270: 2475–2478

    Article  PubMed  CAS  Google Scholar 

  3. Albright AL, Barry MJ, Shafron DH, Ferson SS (2001) Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 43: 652–657

    Article  PubMed  CAS  Google Scholar 

  4. Albright AL, Gilmartin R, Swift D, Krach LE, Ivanhoe CB, McLaughin JF (2003) Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 98: 291–295

    PubMed  CAS  Google Scholar 

  5. Amano M, Kubo T (1993) Involvement of both GABA A and GABA B receptors in tonic inhibitory control of blood pressure at the rostral ventrolateral medulla of the rat. Naunyn-Schmiedeberg’s Arch Pharmacol 348: 146–153

    Article  CAS  Google Scholar 

  6. Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrel K (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87: 409–414

    PubMed  CAS  Google Scholar 

  7. Ashworth B (1964) Preliminary trial of carisoprodol in multiple sclerosis. Practicioner 192: 540–542

    CAS  Google Scholar 

  8. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B (1996) Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 77: 35–39

    Article  PubMed  CAS  Google Scholar 

  9. Baguley IJ, Nicholls JL, Felmingham KL, Crooks J, Gurka JA, Wade LD (1999) Dysautonomia after traumatic brain injury: a forgotten syndrome? J Neurol Neurosurg Psychiatry 67: 39–43

    PubMed  CAS  Google Scholar 

  10. Barnes MP (2001) Medical management of spasticity in stroke. Age Ageing 30Suppl 1: 13–16

    PubMed  Google Scholar 

  11. Barry MJ, VanSwearingen JM, Albright AL (2000) Intrathecal baclofen therapy and the role of the physical therapist. Ped Phy Ther 12: 77–86

    Google Scholar 

  12. Becker R, Alberti O, Bauer BL (1997) Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 244: 160–166

    Article  PubMed  CAS  Google Scholar 

  13. Becker R, Sure U, Petermeyer M, Bertalanffy H (1999) Continuous intrathecal baclofen infusion alleviates autonomic dysfunction in patients with severe supraspinal spasticity. J Neurol Neurosurg Psychiatry 66: 114–125

    PubMed  CAS  Google Scholar 

  14. Becker R, Benes L, Sure U, Hellwig D, Bertallanfy H (2000) Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. J Clin Neurosci 7: 316–319

    Article  PubMed  CAS  Google Scholar 

  15. Boeve BF, Wijdicks EFM, Benarroch EE, Schimdt KD (1998) Paroxysmal sympathetic storms (diencephalic seizures) after severe diffuse axonal head injury. Mayo Clinics Proceedings 73: 148–152

    CAS  Google Scholar 

  16. Bohannon RW, Smith MB (1987) Inter rater reliability of a modified Ashworth Scale of muscle spasticity. Phys Ther 67: 206–207

    PubMed  CAS  Google Scholar 

  17. Boviatsis E, Kouyialis AT, Korfias S, Sakas DE (2005) Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 107: 289–295

    Article  PubMed  Google Scholar 

  18. Bowery NG (1993) GABA B receptor pharmacology. Annu Rev Pharmacol Toxicol 33: 109–147

    PubMed  CAS  Google Scholar 

  19. Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, Enna SJ (2002) International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid (B) receptors: structure and function. Pharmacol Rev 54: 247–264

    Article  PubMed  CAS  Google Scholar 

  20. Burns AS, Meythaler J (2001) Intrathecal baclofren in tetraplegia of spinal origin: efficacy for upper extremity hypertonia. Spinal Cord 39: 413–419

    Article  PubMed  CAS  Google Scholar 

  21. Campbell SK, Almeida GL, Penn RD, Corcos DM (1995) The effects of intrathecally administered baclofen on function in patients with spasticity. Phys Ther 75: 352–362

    PubMed  CAS  Google Scholar 

  22. Carswell A, McColl MA, Baptiste S, Law M, Polatajko H, Pollock N (2004) The Canadian occupational performance measure: a research and clinical literature review. Can J Occup Ther 71: 210–222

    PubMed  Google Scholar 

  23. Coffrey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, Sadiq SA, Turner MS (2002) Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 83: 735–741

    Article  Google Scholar 

  24. Cuny E, Richrer E, Castel JP (2001) Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: relief with intrathecal baclofen therapy. Brain Inj 15: 917–925

    Article  PubMed  CAS  Google Scholar 

  25. Dones I (2006) Intrathecal baclofen for the treatment of spasticity: selection criteria, management and efficacy in the wheel-chaired and bedridden versus the mobile patients. Acta Neurochir Suppl (in press)

    Google Scholar 

  26. Dykstra DD, Mendez A, Chappuis D, Baxter T, DesLauriers L, Stuckey M (2005) Treatment of cervical dystonia and focal hand dystonia by high cervical continuously infused intrathecal baclofen: a report of two cases. Arch Phys Med Rehabil 86: 830–833

    Article  PubMed  Google Scholar 

  27. Dykstra D, Stuckey M, DesLauries L, Chappuis D, Krach L (2006) Intrathecal baclofen in the treatment of spasticity: indications, selection criteria, management and outcome in the adult versus the pediatric population. Acta Neurochir Suppl (in press)

    Google Scholar 

  28. Fann S (1988) Concept and classification of dystonia. Adv Neurol 50: 1–8

    Google Scholar 

  29. Fox S, Krnjevic K, Morris ME, et al (1978) Action of baclofen on mammalian synaptic transmission. Neuroscience 3: 495–515

    Article  PubMed  CAS  Google Scholar 

  30. Francisco GE (2001) Can intrathecal baclofen therapy unleash functional recovery after stroke? Stroke 32: 2108–2109

    Google Scholar 

  31. Gatscher S, Becker R, Uhle E, Bertalanffy H (2002) Combined intrathecal baclofen and morphine infusion for the treatment of spasticity related pain and central deafferentation pain. Acta Neurochir Suppl 79: 75–76

    PubMed  CAS  Google Scholar 

  32. Gerszten PC, Albright AL, Johnstone GF (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 88: 1009–1013

    Article  PubMed  CAS  Google Scholar 

  33. Gianino JM, York MM, Paice JA, Shott S (1998) Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 30: 47–54

    PubMed  CAS  Google Scholar 

  34. Grabb PA, Guin-Renfroe S, Meythaler JM (1999) Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity. Neurosurgery 45: 833–836

    Article  PubMed  CAS  Google Scholar 

  35. Grades JM, Nance P, Elovic E, McGuire J, Simpson DM (1997) Traditional pharmacological treatments for spasticity. Part III: General and regional treatments. Muscle Nerve Suppl 6: S92–S120

    Google Scholar 

  36. Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G (2005) A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil 86: 2165–2171

    Article  PubMed  Google Scholar 

  37. Hagglund G, Andersson S, Duppe H, Pedertsen HL, Nordmark E, Westbom L (2005) Prevention of severe contractures might replace multilevel surgery in cerebralpalsy: results of a population-based health care programme and new techniques to reduce spasticity. J Pediatr Orthop B 14: 269–273

    PubMed  Google Scholar 

  38. Herman RM, D’Luzansky JC, Ippolito R (1992) Intrathecal baclofen suppresses central pain in patients with spinal lesions. Clin J Pain 8: 338–345

    PubMed  CAS  Google Scholar 

  39. Horn TS, Yablon SA, Stokic DS (2005) Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil 86: 1127–1133

    Article  PubMed  Google Scholar 

  40. Ivanhoe CB, Reistetter TA (2004). Spasticity: the misunderstood part of the upper motor neuron syndrome. Am J Phys Med Rehabil 83[Suppl]: S3–S9

    Article  PubMed  Google Scholar 

  41. Kendal DA, Browner M, Emma SJ (1982) Comparison of the antinoceceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement. J Pharmacol Exp Therap 220: 482–487

    Google Scholar 

  42. Kroin JS, Penn RD (1991) Cerebrospinal fluid pharmacokinetics of lumbar intrathecal baclofen. In: Lakke JPWF, Delhaas EM, Rutgers AWE (eds) Parenteral drug therapy in spasticity and Parkinson’s disease. Parthenon Publishing, Canforth UK, pp 73–83

    Google Scholar 

  43. Kroin J, Ali A, York M, Penn RD (1993) The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 33: 226–230

    Article  PubMed  CAS  Google Scholar 

  44. Kyriagis M, Grattan-Smith P, Scheinberg A, Teo C, Nakaji N, Waugh M (2004) Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. J Paediatr Child Health 40: 322–325

    Article  PubMed  CAS  Google Scholar 

  45. Lance JW (1980) Symposium Synopsis. In: Feldman RG, Young RR, Kellas WP (eds) Spasticity, disordered motor control. Year Book Medical Publishers, CIBA-GEIGY Corporation, Chicago, pp 485–494

    Google Scholar 

  46. Law M, Baptiste S, McColl MA, Opzoomer A, Polatajko H, Pollock N (1990) The Canadian occupational performance measure: an outcome measure for occupational therapy. Can J Occup Ther 57: 82–87

    PubMed  CAS  Google Scholar 

  47. Levy RA, Proudfit HK (1979) Analgesia produced by microinjection of balcofen and morphine at brainstem sites. Eur J Pharmacol 57: 43–55

    Article  PubMed  CAS  Google Scholar 

  48. Lind G, Meyerson BA, Winter J, Linderoth B (2004) Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: a pilot study. Eur J Pain 8: 377–383

    Article  PubMed  CAS  Google Scholar 

  49. Lind G, Schechtmann G, Winter J, Linderoth B (2006) Drugenhanced spinal stimulation for pain: a new strategy. Acta Neurochir Suppl (in press)

    Google Scholar 

  50. Loubser PG, Akman NM (1996) Effects of intrathecal baclofen on chronic spinal cord injury pain. J Pain Symptom Manage 12: 241–247

    Article  PubMed  CAS  Google Scholar 

  51. Marquardt G, Lorenz R (1999) Intrathecal baclofen for intratable spasticity in amyotrophic lateral sclerosis. J Neurol 246: 619–620

    Article  PubMed  CAS  Google Scholar 

  52. Marquardt G, Seifert V (2002) Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 72: 275–276

    Article  PubMed  CAS  Google Scholar 

  53. Mayer NH (2002) Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motor neuron lesion. In: Mayer NH, Simpson DM (eds) Spasticity: etiology, management and the role of botulinum toxin. We Move, New York, pp 1–11

    Google Scholar 

  54. Medtronic (The) (2002) ITB Therapy Clinical Reference Guide for Spasticity Management UC19961184cEN NP 2584c, Medtronic, Inc

    Google Scholar 

  55. Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworht CS (1992) Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 71: 321–327

    Article  PubMed  CAS  Google Scholar 

  56. Meythaler JM, Steers WD, Tuel SM, Cross LL, Sesco DC, Haworth CS (1992) Intrathecal baclofen in hereditary spastic paraparesis. Arch Phys Med Rehabil 73: 794–797

    PubMed  CAS  Google Scholar 

  57. Meythaler JM, Devivo JH, Hadely M (1996) Prospective study on the use sof bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil 77: 461–466

    Article  PubMed  CAS  Google Scholar 

  58. Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN (1999) Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil 80: 13–19

    Article  PubMed  CAS  Google Scholar 

  59. Meythaler JM, Guin-Renfroe S, Hadley MN (1999) Continuously infused intrathecal baclofen for spastic=dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil 78: 247–254

    Article  PubMed  CAS  Google Scholar 

  60. Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN (2001) Intrathecal baclofen for spastic hypertonia from stroke. Stroke 32: 2099–2109

    PubMed  CAS  Google Scholar 

  61. Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadely MN (2001) Continuously infused intrahtecal baclofen over 12 months for spastic hyperTonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil 81: 155–161

    Article  Google Scholar 

  62. Middleton JW, Siddell PJ, Walker S, Molloy AR, Rutkowski SB (1996) Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study. Arch Phys Med Rehabil 77: 824–826

    Article  PubMed  CAS  Google Scholar 

  63. Molteni F, Carda S, Cazzaniga M, Magoni L, Rossini M, Caimmi M (2005) Instrumental evaluation of gait modifications before and during intrathecal baclofen therapy: a 2-year follow-up case study. Am J Phys Med Rehabil 84: 303–306

    Article  PubMed  Google Scholar 

  64. Murphy NA, Irwin MCN, Hoff C (2002) Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch Phys Med Rehabil 83: 1721–1725

    Article  PubMed  Google Scholar 

  65. Ochs G, Struppler A, Meyerson BA, Linderoth B, Gybels J, Gardner BP, Teddy P, Jamous A, Weinmann P (1989) Intrathecal baclofen for long-term treatment of spasticity: a multicenter study. J Neurol Neurosurg Psychiatry 52: 933–939

    Article  PubMed  CAS  Google Scholar 

  66. Ordia JI, Fischer E, Adamski E, Chagnon KG, Spatz EL (2002) Continuous intrathecal baclofen infusion by a programmable pump in 131 consecutive patients with severe spasticity of spinal origin. Neuromodulation 5: 16–24

    Article  Google Scholar 

  67. Penn R, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity [letter]. Lancet 1: 1078

    Article  PubMed  CAS  Google Scholar 

  68. Penn R, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet 2: 125–127

    Article  PubMed  CAS  Google Scholar 

  69. Penn RED, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, Kroin JS (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320: 1517–1521

    PubMed  CAS  Google Scholar 

  70. Petropoulou K, Panourias IG, Rapidi CA, Sakas DE (2006) The importance of neurorehabilitation to the outcome of neuromodulation in spasticity. Acta Neurochir Suppl (in press)

    Google Scholar 

  71. Petropoulou K, Panourias IG, Rapidi CA, Sakas DE (2006) The phenomenon of spasticity: a pathophysiological and clinical introduction to neuromodulation therapies. Acta Neurochirurgica Suppl (in press)

    Google Scholar 

  72. Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathe JF, Richard I (2004) Treatment of spasticity with intrathecal baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42: 686–693

    Article  PubMed  CAS  Google Scholar 

  73. Pohl M, Rockstroh G, Ruckriem S, Mehrholz J, Pause M, Koch R, Strik H (2003) Time course of the effect of a bolus dose of intrathecal baclofen on severe cerebral spasticity. J Neurol 250(10): 1195–1200

    Article  PubMed  CAS  Google Scholar 

  74. Remy-Neris O, Tiffreau V, Bouilland S, Bussel B (2003) Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait. Arch Phys Med Rehabil 84: 643–650

    Article  PubMed  Google Scholar 

  75. Ridley B (2006) Intrathecal baclofen therapy: challenges in patients with multiple sclerosis. Rehabil Nurs 31: 158–164

    PubMed  Google Scholar 

  76. Saitoh K, Konish S, Otsuka M (1975) Antagonism between lioresal and substance P in rat spinal cord. Brain Res 97: 177–180

    Article  Google Scholar 

  77. Sallerin B, Lazorthes Y (2003) Intrathecal baclofen. Experimental and pharmacokinetic studies. Neurochirurgie 49: 271–275

    PubMed  CAS  Google Scholar 

  78. Sawynok J, Reid A (1986) Role of ascending and descending noradrenergic pathways in the antinociceptive effect of baclofen and clonidine. Brain Res 386: 341–350

    Article  PubMed  CAS  Google Scholar 

  79. Shakespeare DT, Boggild M, Young C (2001) Anti-spasticity agents for multiple sclerosis. Cocbrane Databse Syst Rev, CD001332

    Google Scholar 

  80. Silbert PL, Matsumoto JY, McManis PG, Stolp-Smith KA, Elliott BA, McEvoy KM (1995) Intrathecal baclofen therapy in stiff-man syndrome: a double-blind, placebo-controlled trial. Neurology 45: 1893–1897

    PubMed  CAS  Google Scholar 

  81. Sitaram BR, Tsui M, Rawicki HB, Sitaram M (1997) Stability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphine. Int J Pharmaceutics 153: 13–24

    Article  CAS  Google Scholar 

  82. Slonimski M, Abram SE, Zuniga RE (2004) Intrathecal baclofen in pain management. Reg Anesth Pain Med 29: 269–276

    Article  PubMed  CAS  Google Scholar 

  83. Smail DB, Jacq C, Denys P, Bussel B (2005) Intrathecal baclofen int eh treatment of painful, disabling spasms in Friedreich’s ataxia. Mov Disord 20: 758–759

    Article  PubMed  Google Scholar 

  84. Stempien L, Tsai T (2000) Intrathecal baclofen pump use for spasticity. Am J Phys Med Rehabil 79: 536–541

    Article  PubMed  CAS  Google Scholar 

  85. Taira T, Hori T (2006) Intrathecal baclofen in the treatment of post-stroke central pain, dystonia, and persistent vegetative state. Acta Neurochir Suppl (in press)

    Google Scholar 

  86. Taira T, Kawamura H, Tanikawa T, Iseki H, Kawabatake H, Takakura K (1995) A new approach to control central deafferentiation pain: Spinal intrathecal baclofen. Stereotactic Funct Neurosurg 65: 101–105

    Article  CAS  Google Scholar 

  87. Takenaka K, Sasaki S, Nakamura K, Uchida A, Fujita H, Itoh H, Nakata T, Takeda K, Nakagawa M (1995) Hypothalamic and medullary GABAA and GABAB-ergic systems differently regulate sympathetic and cardiovascular systems. Clin Exp Pharmacol Physiol Suppl 22: S48–S50

    PubMed  CAS  Google Scholar 

  88. Tsui M, Lam S (1992) Stability of intrathecal baclofen and morphine (Letter). Aust J Hosp Pharm 22: 258

    Google Scholar 

  89. Turner MS (2003) Early use of intrathecal baclofen in brain injury in pediatric patients. Acta Neurochir Suppl 87: 81–83

    PubMed  CAS  Google Scholar 

  90. van Hilten BJ, van de Beek WJ, Ho JI, Voormolen JH, Delhaas EM (2000) Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 343: 625–630

    Article  PubMed  Google Scholar 

  91. Vasconcelos OM, Dalakas MC (2003) Stiff-person syndrome. Curr Treat Options Neurol 5: 79–90

    PubMed  Google Scholar 

  92. Vatine JJ, Magora F, Swissa A, Magora A (1989) Effect of intrathecal baclofen in low back pain with root compression symptoms. Pain Clin 2: 207–217

    Google Scholar 

  93. Vloeberghs M (2002) Intrathecal baclofen in the management of spasticity due to cerebral palsy. Adv Clin Neurosci Rehabil 2: 11–13

    Google Scholar 

  94. Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF (2000) Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord 15: 1242–1247

    Article  PubMed  CAS  Google Scholar 

  95. Wilson P, Yaksh TL (1978) Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacology 51: 323–320

    Article  CAS  Google Scholar 

  96. Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS (2004) Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry 75: 1553–1557

    Article  PubMed  CAS  Google Scholar 

  97. Zhang SJ, Jackson MB (1993) GABA-activated chloride channels in secretory nerve endings. Science 259: 531–534

    Article  PubMed  CAS  Google Scholar 

  98. Zuniga RE, Schlicht CR, Abram SE (2000) Intrathecal baclofen is analgesic in patients with chronic pain. Anesthesiology 92: 876–880

    Article  PubMed  CAS  Google Scholar 

  99. Zuniga RE, Perera S, Abram SE (2002) Intrathecal baclofen; a useful agent in the treatment of well-established complex regional pain syndrome. Reg Anesth Pain Med 27: 90–93

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. P. S. Kokkalis Hellenic Center for Neurosurgical Research, 3 Ploutarchou Str, Athens, 10675, Greece

    I. G. Panourias, M. Themistocleous & Damianos E. Sakas

Authors
  1. I. G. Panourias
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Themistocleous
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Damianos E. Sakas
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Neurosurgery, University of Athens, Athens, Greece

    Damianos E. Sakas

  2. University Hospital of Wales, Cardiff, UK

    Brian A. Simpson

  3. Pacific Pain Treatment Centers, San Francisco, USA

    Elliot S. Krames

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag

About this chapter

Cite this chapter

Panourias, I.G., Themistocleous, M., Sakas, D.E. (2007). Intrathecal baclofen in current neuromodulatory practice: established indications and emerging applications. In: Sakas, D.E., Simpson, B.A., Krames, E.S. (eds) Operative Neuromodulation. Acta Neurochirurgica Supplements, vol 97/1. Springer, Vienna. https://doi.org/10.1007/978-3-211-33079-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-33079-1_20

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-33078-4

  • Online ISBN: 978-3-211-33079-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation